Biochemistry Analyzers Market

Overview-

Biochemistry analyzers are clinical chemical analyzing devices which measures components in biological sample including blood urine, plasma. It uses many electrochemical and optical techniques to analyze blood, urine, cerebrospinal fluid and other biological samples. Function of these analyzers is mostly based on optical measurements which includes calorimetric, absorption, spectrometric and fluoroscopic detection.

These processes can measure chemicals such as antigens molecules and proteins in the body fluid. These analyzers are mostly used in hospitals, clinics, epidemic prevention stations. Biochemical analyzers are made up of optical engine which includes light source, detectors, and other optical elements. For greater accuracy biochemistry analyzers are highly automated. It automates sample loading tube cleaning mechanical control and data processing.

The user just needs to insert sample for analysis, choose the program and starts the instrument. These analyzers are not only used in medical field but also used in research industries and diagnosis of various diseases. Main aim of these analyzers is in medical field as they are safe to use in hospital laboratories. They are used to perform many tests like sugar test, albumin test.

Industry Insights-

• The Global Biochemistry Analyzers Market was valued at USD 3.53 Billion in 2021
• It is anticipated to reach USD 5.18 Billion by 2028
• A CAGR of 5.6% is anticipated over the forecast period

Key Players-

Some of the key players for global biochemistry analyzers market are

• Abbott
• Danaher
• F. Hoffmann-La-Roche Ltd.
• Meril Life Science Pvt. Ltd.
• Siemens AG
• Hologic Inc.
• Thermo Fisher Scientific Inc.
• Randox Laboratories Ltd.
• Beckman Coulter Inc.
• Horiba Ltd
• Erba
• Microlab
• RMS
• Mindray
• others

Segmentation Analysis-

By Type:

• Fully Automatic Biochemistry Analyzers
• Semi-Automatic Biochemistry Analyzers

The global market for biochemistry analyzers can be divided into two types: fully automated and semi-automated systems. Semi-automated systems, which are significantly more cost-effective, take up the majority of the market share by volume. These analyzers are typically used in small diagnostic labs with low sample volumes, such as in clinics or hospitals, while automated systems are used in larger labs with high sample volumes. The trend towards automation in the industry could lead to a faster growth in the market for automated analyzers.

By End-Users:

• Hospital and Diagnostic Laboratories
• Home Care
• Academic and Research Institutes

The global biochemistry analyzers market is segmented by end-users into hospitals, diagnostic labs, research institutions, and others. Diagnostic labs account for the largest revenue share in the market due to the high capital costs associated with the installation of these machines. However, hospitals are expected to be the fastest-growing segment during the forecast period as a result of the demand for faster results, along with the increasing availability of small-scale and point-of-care analyzers.

By Configuration:

• Floor-Standing
• Bench-top Analyzers

The global market for biochemistry analyzers is divided into floor-standing and bench-top analyzers. Floor-standing analyzers are the largest revenue generators, while bench-top analyzers account for the highest volume. Floor-standing analyzers are bigger and faster than bench-top analyzers, but they are more expensive and their size restricts them to core diagnostic laboratories.

By Regional & Country Analysis

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC

Latin America

• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

The global biochemistry analyzers market is segmented into North America, Europe, Asia-Pacific Latin America, and Middle East & Africa. North America is expected to dominate the market within the forecast period attributed to key players launching new biochemistry analyzers for diagnosis purpose and highly developed healthcare industry in this region.

Biochemistry analyzers are used to analyze, to detect and to determine various functions of biomolecules within the cell. Analyzing biomolecules is important for disease diagnostics, food safety inspection and pharmaceutical development. Europe is projected to capture the second largest share of global biochemistry analyzers market due to growing geriatric population, rising prevalence of chronic diseases, and increasing number of product offerings in this region. For example; in November 2019, JEOL.LTD launched its biomajesty series of chemistry analyzers which includes JCA-ZS050, JCA-BM6070/C and JCA-BM6010/C.

Covid-19 Impact-

Covid-19 has shown a positive impact on global biochemistry analyzer market due increased demand of laboratory tests to diagnose and monitor Covid-19. So that demand of global biochemistry market is increased.

However, limited tests used in the diagnosis and monitoring of COVID-19, delay of non-urgent health issues because of the pandemic and decrease in the number of patients due to concern of contagion have led to a drop in test numbers which has affected the market growth up to some extent.

Market Drivers-

Growing demand of biochemistry analyzers in hospitals and rising demand of automated analyzers

As biochemistry analyzers also known as clinical chemistry analyzers, they are used to measure metabolites present in biological samples like blood urine. By studying these samples, it is possible to diagnose many diseases. In addition, increasing number of product launches in this field is also supplementing the market growth. For instance; in September 2020, Agappe diagnostics launched a new hematology analyzer.

Increasing prevalence of chronic diseases

In addition, growing number of cases of chronic diseases is also propelling the growth of the market. As there are number of cases of chronic diseases increasing, there is more demand of analyzers to detect the body biomolecules. Aging population and changes in societal behavior causes steady increase in these chronic diseases.

For example; according to international federation (IDF), 463 million people worldwide had diabetes in 2019, a 62% increase since 2009. Therefore, to detect these chronic diseases by using body fluids there is increasing demand of analyzers which boosts the growth of the market.

Opportunities-

Development of analyzers along with low volume reagent consumption to create new opportunities

The introduction of the new biochemistry analyzers has significantly improved the efficiency of sample analysis, as it has reduced the number of reagents used and the time needed to complete repetitive tasks. Furthermore, the automation of sample analysis has improved the accuracy of results, as it eliminates the potential for human error. Finally, the use of discrete systems has increased the safety of lab technicians, as it reduces the amount of exposure to hazardous reagents.

Recent Developments-

• On February 1st, 2021; DxH 560 AL was launched by Beckman Coulter, a tabletop hematology analyzer. This analyzer is made to reduce the time and resource restrictions faced by small to midsized laboratories. This analyzer includes automatic loading functionality, closed tube aspiration and easy to carry capabilities. At a time 50 samples can fit into it and it also provide safety against blood-borne pathogens. The DxH 560 analyzer provides result in 60 seconds or less. This analyzer can be used in case of patients like infants, cancer patients or elderly patients. Because it only requires a 17 μL sample less than a drop of blood. The analyzer also offers privacy and security features including customizable user login, paperless data management and fully traceable automated timeouts. This analyzer is a part of Beckman coulters DxH500 series of small footprint tabletop hematology analyzer.

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2022 - 2028
Market Size in 2021:	USD 3.53 Billion
Base year considered	2020
Forecast Period CAGR %:	5.6%
Market Size Expected in 2028:	USD 5.18 Billion
Tables, Charts & Figures:	175
Pages	300
Key Players/Companies	Abbott, Danaher, F. Hoffmann-La-Roche Ltd., Meril Life Science Pvt. Ltd., Siemens AG, Hologic, Inc., Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Beckman Coulter, Inc., Horiba Ltd, Erba , Microlab, RMS, Mindray, others.
Segments Covered	By Type, By End-Users, By Configuration
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa